Patient support programs: Understanding legal risks

Yet, these programs have come under scrutiny as part of the debate over drug prices and present potential legal risks to the life sciences companies that sponsor or support them.

Join our panel of Hogan Lovells lawyers for a discussion of the key risks in this area and how to best minimize them, including: 

  • Hot topics around U.S. Department of Justice investigations and relevant takeaways
  • Best practices for structuring patient support programs to mitigate the risk of legal challenges and government enforcement actions
  • Product liability implications and how to limit exposure
  • The European law perspective

Click here to register.

Back To Listing